Last patient completed pivotal Phase 3 trial in CHB-associated liver fibrosis in the PRC with data expected in Q1 2025On track to initiate U.S.

In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Springworks Therapeutics (SWTX – Research ...

Sanofi S.A. Part Cert 0.06% €8.19M ...

Dyne Therapeutics Inc.-2.70% $2.94B ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

Dan Diamond is a national health reporter for The Washington Post, focused on accountability, federal agencies and public health. He joined The Post in 2021 after covering the Trump administration ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

After hours: November 11 at 6:37 PM EST Loading Chart for STOK ...